$0.00—Stale · unknown old
OTC • Last print unknown ago
$0.00—Stale · unknown old
BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress
UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM)
BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update
BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal
BioAdaptives Inc. Opens Commercial Ordering Window for XcellaraHeart(TM) Cellular Wellness Formula
BioAdaptives Inc. Eliminates Major Market Overhang by Retiring the Debt of the Largest Convertible Commercial Investor
BioAdaptives Inc. Reports Scaling of E-Commerce Footprint and Consumer Reach for MyndSystem(TM) Nootropic Platform
This Wide Moat ETF Could Be 2025 Star
BioAdaptives Announces Nationwide Launch of Lung Fortress™ Natural Supplement